Is a synthetic peptide derived from erythropoietin (EPO), but without its effect on red blood cell production. It selectively targets tissue-protective receptors, helping reduce inflammation and support cellular repair.

The peptide is actively studied for its neuroprotective and anti-inflammatory properties. It may help reduce pain, support nervous system health, and provide benefits in various metabolic and neurological conditions.

ARA 290 also shows potential in improving insulin sensitivity and promoting tissue recovery after damage. Despite promising research results, it remains an experimental compound and should be used with caution.